BridgeBio Pharma, Inc. (BBIO)
67.16
-0.21
(-0.31%)
USD |
NASDAQ |
Jun 09, 14:44
BridgeBio Pharma SG&A Expense (Quarterly) : 163.90M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.961B |
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Ionis Pharmaceuticals, Inc. | 150.36M |
| BioMarin Pharmaceutical, Inc. | 258.30M |
| Cytokinetics, Inc. | 104.90M |